Psychopharm Today

In this episode of “Psychopharm Today,” host Jenessa Johnston, PhD, and guests James Murrough, MD, PhD, of the Icahn School of Medicine at Mount Sinai, and Hiroe Hu, DO, a clinical research fellow in the National Institute of Mental Health's (NIMH) Experimental Therapeutics and Pathophysiology Branch, discuss the case for entactogens in mood and anxiety disorders. The conversation explores enta...

Metabolic syndrome screening is important for all patients with psychiatric disorders, not just those on antipsychotics. Careful communication of metabolic risk is needed to avoid unintended consequences, such as medication nonadherence. In the second episode of “Psychopharm Today,” host Jessica Gannon, MD, and guests Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD...

“Psychopharm Today” is a video-podcast series, created collaboratively with the American Society of Clinical Psychopharmacology (ASCP) (https://www.psychiatrictimes.com/sap-partner/american-society-of-clinical-psychopharmacology) , in which members converse about the latest hot topics in psychopharmacology. Suicide is the eleventh leading cause of death overall in the United States, claiming t...